Mechanisms of Kringle Fragment of Urokinase-Induced Vascular Smooth Muscle Cell Migration

Journal of Surgical Research

Volumn 141, Issue 1, 2007, Pages 83-90

  Roztocil, Elisa ^a   Nicholl, Suzanne M ^a   Davies, Mark G ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

cell signaling; kringle fragment of urokinase; migration; urokinase; vascular smooth muscle cell

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AMINOCAPROIC ACID; APROTININ; EPIDERMAL GROWTH FACTOR RECEPTOR; ILOMASTAT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PERTUSSIS TOXIN; PROTEIN KINASE B; UROKINASE; WORTMANNIN;

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; KRINGLE DOMAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; GTP-BINDING PROTEINS; KRINGLES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; URINARY PLASMINOGEN ACTIVATOR;

EID: 34250202905     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.03.069     Document Type: Article

References (41)

1. Blasi F. The urokinase receptor: A cell surface regulated chemokine. APMIS 107 (1999) 96
2. Blasi F., Vassalli J.-D., and Dang K. Urokinase type plasminogen activator: proenzyme, receptor and inhibitors. J Cell Biol 104 (1987) 801
3. Nicholl S.M., Roztocil E., and Davies M.G. Urokinase (uPA) induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. J Vasc Surg 41 (2005) 672
4. Tanski W.J., Fegley A.J., Roztocil E., et al. Domain dependent actions of urokinase on smooth muscle cell responses. J Vasc Surg 39 (2004) 214
5. Resnati M., Guttinger M., Valcamonica S., et al. Proteolytic cleavage of the urokinase receptor substitutes for agonist-induced chemotactic effects. EMBO J 15 (1996) 1572
6. Fazioli F., Resnati M., Sidenius N., et al. A urokinase sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J 16 (1997) 7279
7. Stepanova V., Mukhina S., Kohler E., et al. Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor dependent and proteolysis-dependent mechanisms. Mol Cell Biochem 195 (1999) 199
8. Stepanova V., Bobik A., Bibilashvity R., et al. Urokinase plasminogen activator induces smooth muscle cell migration: key role of growth factor-like domain. FEBS Lett 414 (1997) 471
9. Stephens R.W., Bokman A.M., Myohanen H.T., et al. Heparin binding to the urokinase kringle domain. Biochemistry 31 (1992) 7572
10. MAPK activation. J Surg Res 113 (2003) 32
11. Galaria I.I., Nicholl S.M., Roztocil E., et al. Urokinase-induced smooth muscle cell migration requires both PI3-K / akt and PI3-K/ERK1/2 activation. J Surg Res 127 (2005) 46
12. Ui M., Katada T., Murayama T., et al. Selective blockage by Islet-activating protein, pertussis toxin: A probe for functions of the inhibitory guanine nucleotide regulatory component of adenylate cyclase. Trends Pharmacol Sci 5 (1984) 277
13. Tanski W.J., Roztocil E., and Davies M.G. Sphingosine-1-phosphate induces Gαi-coupled, PI3K/ras dependent smooth muscle cell migration. J Surg Res 108 (2002) 98
14. Nakanishi S., Kakita S., Takahashi I., et al. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem 267 (1992) 2157
15. Powis G., Bonjouklian R., Berggren M., et al. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res 54 (1994) 2419
16. Duan C., Bauchat J.R., and Hsieh T. Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration. Circ Res 86 (2000) 15
17. Vlahos C., Matter W., Hui K., et al. A specific inhibitor of phosphatidylinositol 3kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269 (1994) 5241
18. Alessi D.R., Cuenda A., Cohen P., et al. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 270 (1995) 27489
19. Cuenda A., Rouse J., Doza T.N., et al. SB203580 is specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and IL-1. FEBS Lett 364 (1995) 229
20. Davies S., Reddy H., Caivano M., et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351 (2000) 95
21. Kalmes A., Deou J., Clowes A., et al. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580. FEBS Lett 444 (1999) 71
22. Bendeck M.P., Irvin C., and Reidy M.A. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78 (1996) 38
23. Grobelny D., Poncz L., and Galardy R.E. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry 31 (1992) 7152
24. Tanski W.J., Nicholl S.M., Kim D., et al. Sphingosine-1-phosphate-induced smooth muscle cell migration involves the mammalian target of rapamycin. J Vasc Surg 39 (2005) 91
25. Carmeliet P., Moons L., Lijnen R., et al. Inhibitory role of PAI-1 in arterial wound healing and neointima formation. Circulation 96 (1997) 3180
26. Carmeliet P., Moons L., Herbert J.-M., et al. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res 81 (1997) 829
27. Peng L., Bhatia N., Parker A.C., et al. Endogenous vitronectin and PAI-1 promote neointima formation in murine carotid arteries. Arterioscler Thromb Vasc Biol 22 (2002) 934
28. Korshunov V.A., and Berk B.C. Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening. Arterioscler Thromb Vasc Biol 23 (2003) 2185
29. Korshunov V.A., Solomatina M.A., Plekhanova O.S., et al. Plasminogen activator expression correlates with genetic differences in vascular remodeling. J Vasc Res 41 (2004) 481
30. Blasi F., and Carmeliet P. uPAR: A versatile signaling orchestrator. Nat Cell Biol 3 (2002) 932
31. Preissner K.T., Kanse S.M., and May A.E. Urokinase receptor: a molecular organizer in cellular communication. Curr Opin Cell Biol 12 (2000) 621
32. Hazzalin C.A., and Mahadevan L.C. MAPK regulated transcription: a continuously variable gene switch. Nat Rev Mol Cell Biol 3 (2002) 30
33. MAPK promote neuronal survival in vitro. J NeuroSci Res 52 (1998) 483
34. Graves J.D., Draves K.E., Craxton A., et al. A comparison of signaling requirements for apoptosis of human B lymphocytes induced by the B cell receptor and CD95/Fas. J Immunol 161 (1998) 168
35. Yamauchi J., Tsujimoto G., Kaziro Y., et al. Parallel regulation of mitogen-activated protein kinase kinase (MKK) 3 and 6 (MKK6) in Gq-signaling cascade. J Biol Chem 276 (2001) 23362
36. Calabrese V., Scapagnini G., Ravagna A., et al. Molecular chaperones and their roles in neural cell differentiation. Dev Neurosci 24 (2002) 1
37. Aguirre-Ghiso J.A., and Ossowski L. Urokinase receptor and integrin partnership: co-ordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 12 (2000) 613
38. Wetzker R., and Bohmer F.D. Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 4 (2003) 651
39. Moro L., Dolce L., Cabodi S., et al. Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. J Biol Chem 277 (2002) 9405
40. Shah B.H., Neithardt A., Chu D.B., et al. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs. J Cell Physiol 206 (2006) 47
41. Sieg D.J., Hauck C.R., Ilic D., et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2 (2000) 249